121 - COVID-19 and Special Populations

Moderator(s)

• 

  Emily Blumberg, MD, FIDSA (she/her/hers)

  Professor
  Division of Infectious Diseases
  University of Pennsylvania
  Philadelphia, PA, United States
• 

  Jonathan Li, MD, MMSc

  Associate Professor of Medicine
  Brigham and Women's Hospital, Harvard Medical School
  Boston, MA, United States

Presentations:

• 10:30 AM – 10:45 AM US ET

  Comparison of Demographic and Clinical Characteristics in Survivors Vs. Decedents with Multisystem Inflammatory Syndrome in Children (MIS-C) During the COVID-19 Pandemic—CDC National Surveillance, February 2020-December 2022
  

  Presenting Author: Anna R. Yousaf, MD (she/her/hers) – Centers for Disease Control and Prevention

  Co-Author: Katherine N. Lindsey, MPH – Centers for Disease Control and Prevention

  Co-Author: Ami B. Shah, MPH – General Dynamics Information Technology

  Co-Author: Allison D. Miller, MPH – Centers for Disease Control and Prevention

  Co-Author: Michael J. Wu, MSc – Centers for Disease Control and Prevention

  Co-Author: Michael Melgar, MD (he/him/his) – Centers for Disease Control and Prevention

  Co-Author: Laura D. Zambrano, PhD, MPH (she/her/hers) – Centers for Disease Control and Prevention

  Co-Author: Angela P. Campbell, MD, MPH, FPIDS, FIDSA – Centers for Disease Control and Prevention
• 10:45 AM – 11:00 AM US ET

  Fully Vaccinated Individuals with Immunocompromised Conditions (IC) are Still at Increased Risk of Severe COVID-19 Outcomes From the Omicron Variant: Initial Results From INFORM, a Retrospective Health Database Observational Study in England
  

  Co-Author: Sabada Dube, PhD – Medical Evidence, Vaccines and Immune Therapies Unit, AstraZeneca

  Co-Author: Yi Lu, PhD – Real-World Evidence, Data Analytics, Evidera, London, UK

  Co-Author: Richard McNulty, MD – Medical Affairs, Vaccines and Immune Therapies Unit, AstraZeneca, Cambridge, UK

  Co-Author: Sophie Graham, MSc – Real-World Evidence, Data Analytics, Evidera, London, UK

  Co-Author: Sofie Arnetorp, MS – Health Economics and Payer Evidence, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

  Co-Author: Nahila Justo, PhD, MBA – Real-World Evidence, Data Analytics, Evidera, Stockholm, Sweden and Department of Neurobiology, Care Science and Society, Karolinska Institute, Stockholm, Sweden

  Co-Author: Renata Yokota, PhD – P95, Leuven, Belgium

  Co-Author: Kathryn Evans, MPH – Real-World Evidence, Data Analytics, Evidera, Waltham, MA, USA

  Co-Author: Sudhir Venkatesan, MPH, PhD – Medical and Payer Evidence Statistics, BioPharmaceutical Medical, AstraZeneca, Cambridge, UK

  Co-Author: Mark Yates, PhD – Real-World Evidence, Data Analytics, Evidera, London, UK

  Presenting Author: Sylvia Taylor, PhD, MPH, MBA – Medical Evidence, Vaccines and Immune Therapies Unit, AstraZeneca, Cambridge, UK

  Co-Author: Jennifer Quint, PhD – National Heart and Lung Institute, Imperial College London, London, UK

  Co-Author: Rachael A. Evans, PhD FRCP – University of Leicester
• 11:00 AM – 11:15 AM US ET

  Increased Risk of COVID-19 Hospitalization and Death in Vaccinated Patients with End-Stage Renal Disease (ESRD) and Dialysis: Initial Results from INFORM, a Retrospective Health Database Observational Study in England
  

  Co-Author: Sabada Dube, PhD – Medical Evidence, Vaccines and Immune Therapies Unit, AstraZeneca

  Co-Author: Yi Lu, PhD – Real-World Evidence, Data Analytics, Evidera, London, UK

  Presenting Author: Richard McNulty, MD – Medical Affairs, Vaccines and Immune Therapies Unit, AstraZeneca, Cambridge, UK

  Co-Author: Sophie Graham, MSc – Real-World Evidence, Data Analytics, Evidera, London, UK

  Co-Author: Sofie Arnetorp, MS – Health Economics and Payer Evidence, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

  Co-Author: Nahila Justo, PhD, MBA – Real-World Evidence, Data Analytics, Evidera, Stockholm, Sweden and Department of Neurobiology, Care Science and Society, Karolinska Institute, Stockholm, Sweden

  Co-Author: Renata Yokota, PhD – P95, Leuven, Belgium

  Co-Author: Kathryn Evans, MPH – Real-World Evidence, Data Analytics, Evidera, Waltham, MA, USA

  Co-Author: Sudhir Venkatesan, MPH, PhD – Medical and Payer Evidence Statistics, BioPharmaceutical Medical, AstraZeneca, Cambridge, UK

  Co-Author: Mark Yates, PhD – Real-World Evidence, Data Analytics, Evidera, London, UK

  Co-Author: Sylvia Taylor, PhD, MPH, MBA – Medical Evidence, Vaccines and Immune Therapies Unit, AstraZeneca, Cambridge, UK

  Co-Author: Jennifer Quint, PhD – National Heart and Lung Institute, Imperial College London, London, UK

  Co-Author: Rachael A. Evans, PhD FRCP – University of Leicester
• 11:15 AM – 11:30 AM US ET

  A Prospective Evaluation of SARS-CoV-2 Shedding and Evolution in Immunocompromised Hosts During the Omicron Period — IVY Network, 5 U.S. States, April 11, 2022 – February 1, 2023
  

  Presenting Author: Zoe M. Raglow, MD (she/her/hers) – University of Michigan

  Co-Author: Diya Surie, MD – Centers for Disease Control and Prevention

  Co-Author: James Chappell, MD, PhD – Vanderbilt University Medical Center

  Co-Author: Yuwei Zhu, MS, MD – Vanderbilt University

  Co-Author: Emily T. Martin, PhD, MPH (she/her/hers) – University of Michigan

  Co-Author: Jennie H. Kwon, DO;MSCI – Washington University School of Medicine

  Co-Author: Anne Frosch, MD, MPH – Hennepin County Medical Center

  Co-Author: Amira Mohamed, MD – Montefiore medical center

  Co-Author: Julie Gilbert, MPH, MSI – University of Michigan

  Co-Author: Emily E. Bendall, PhD – University of Michigan

  Co-Author: Auden Bahr, n/a – University of Michigan Medical School

  Co-Author: Natasha B. Halasa, MD, MPH (she/her/hers) – Vanderbilt University Medical Center

  Co-Author: H. Keipp Talbot, MD MPH FIDSA – Vanderbilt University Medical Center

  Co-Author: Carlos G. Grijalva, MD, MPH – Vanderbilt University Medical Center

  Co-Author: Adrienne Baughman, None – Vanderbilt University Medical Center

  Co-Author: Kelsey N. Womack, PhD – Vanderbilt University Medical Center

  Co-Author: Cassandra Johnson, MS – Vanderbilt University Medical Center

  Co-Author: Sydney A. Swan, MPH – Vanderbilt University Medical Center

  Co-Author: Ashley Burroughs, N/A – Centers for Disease Control

  Co-Author: Emilia Koumans, MD MPH – CDC

  Co-Author: Meredith L. McMorrow, MD, MPH (she/her/hers) – CDC/NCIRD/CORVD/SPB

  Co-Author: Jennifer L. Harcourt, PhD – Division of Viral Diseases, Centers for Disease Control and Prevention (CDC)

  Co-Author: Lydia J. Atherton, BS, DVM, PhD – Centers for Disease Control

  Co-Author: Natalie J. Thornburg, Ph.D. – Centers for Disease Control and Prevention

  Co-Author: Wesley H. Self, MD – Vanderbilt University Medical Center

  Co-Author: Adam S. Lauring, MD, PhD – University of Michigan
• 11:30 AM – 11:45 AM US ET

  COVID-19 Reinfections in Older Adults: Risk Factors for Poor Outcomes
  

  Presenting Author: Elizabeth Lando-King, PhD, RN – Minnesota Department of Health

  Co-Author: Keeley Morris, MPH – Minnesota Department of Health

  Co-Author: Scott Seys, PhD, MPH – Minnesota Department of Health

  Co-Author: Zachary Zirnhelt, MPH – Minnesota Department of Health

  Co-Author: Elle Talsma, MPH – Minnesota Department of Health

  Co-Author: Haley Wienkes, MPH – Minnesota Department of Health

  Co-Author: Kathryn Como-Sabetti, MPH – Minnesota Department of Health

  Co-Author: Stephanie Meyer, MPH – Minnesota Department of Health